- NCCN Oncology Research Program Celebrates 10th Anniversary by Closing in on $20 Million in Funding; Program Expands into Developmental Therapies (4/29/2009)
- NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus (4/20/2009)
- Experts Weigh In on Controversial Issue of Determining Value of Cancer Care at NCCN Conference (3/16/2009)
- More Stories ....
Email
Print
Mark
